✦ LIBER ✦

Nanotechnology in cancer therapy

✍ Scribed by Aslan, Burcu; Ozpolat, Bulent; Sood, Anil K.; Lopez-Berestein, Gabriel

Book ID: 121269135
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 503 KB
Volume: 21
Category: Article
ISSN: 1061-186X
DOI: 10.3109/1061186X.2013.837469

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer nanotechnology: application of na

Cancer nanotechnology: application of nanotechnology in cancer therapy

✍ Ranjita Misra; Sarbari Acharya; Sanjeeb K. Sahoo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 628 KB

Nanotechnology for breast cancer therapy

✍ Takemi Tanaka; Paolo Decuzzi; Massimo Cristofanilli; Jason H. Sakamoto; Ennio Ta 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 679 KB

Nanotechnology for targeted cancer thera

Nanotechnology for targeted cancer therapy

✍ Wang, May D ;Shin, Dong M ;Simons, Jonathan W ;Nie, Shuming 📂 Article 📅 2007 🏛 Expert Reviews 🌐 English ⚖ 74 KB

Nanotechnology for antiangiogenic cancer

Nanotechnology for antiangiogenic cancer therapy

✍ Kobayashi, Hanako; Lin, P Charles 📂 Article 📅 2006 🏛 Future Medicine 🌐 English ⚖ 459 KB

Clinical Developments in Nanotechnology

Clinical Developments in Nanotechnology for Cancer Therapy

✍ Jeremy D. Heidel; Mark E. Davis 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 540 KB

Mitochondria and Cancer || Mitochondrial

Mitochondria and Cancer || Mitochondrial Nanotechnology for Cancer Therapy

✍ Weissig, Volkmar 📂 Article 📅 2008 🏛 Springer New York 🌐 English ⚖ 356 KB

Nearly a century of scientific research has revealed that mitochondrial dysfunction is one of the most common and consistent phenotypes of cancer cells. A number of notable differences in the mitochondria of normal and cancer cells have been described. These include differences in mitochondrial meta